Nyxoah Plans US Public Offering as it Seeks NASDAQ Listing
Medical technology firm Nyxoah SA announced plans for a public offering of ordinary shares in the United States. The company is also seeking a listing on the NASDAQ Global Market.
Mont-Saint-Guibert, Belgium – Medical technology company Nyxoah SA announced on June 25, 2021, that it is launching a proposed underwritten registered public offering of ordinary shares in the United States. The offering is intended to raise capital and support the company's progression towards a listing on the NASDAQ Global Market.
The company plans to offer 2,760,000 ordinary shares, with an option for underwriters to purchase an additional 15%. Nyxoah has applied to list its ordinary shares on the NASDAQ Global Market under the symbol "NYXH". The company's shares are currently listed on Euronext Brussels.
Piper Sandler, Stifel, and Cantor are acting as joint book-running managers for the offering, with Degroof Petercam serving as a co-manager. The final terms of the offering, including the price per share and the number of shares sold, are subject to market conditions. The company's board of directors has also approved a conditional capital increase for the issuance of up to 4,600,000 ordinary shares.
Nyxoah focuses on the development and commercialization of solutions for Obstructive Sleep Apnea (OSA). The US public offering and planned NASDAQ listing represent significant steps in the company's growth strategy and efforts to expand its international presence.